Latest News

Blocking key enzyme minimizes stroke injury, research finds

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, research suggests. The development of a Cdk5 inhibitor as an acute neuroprotective therapy has the potential to reduce stroke injury, researchers report.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Genes exhibit different behaviours in different stages of development

  • Human skin cells reprogrammed directly into brain cells

  • Bipolar disorder discovery at the nano level

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Stress-related inflammation may increase risk for depression

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • Key factor in transition from moderate to problem drinking

  • Immune proteins moonlight to regulate brain-cell connections

  • Fight against Alzheimer's disease: New research on walnuts

  • Why your brain makes you reach for junk food

  •